Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2014
11/11/2014US8883782 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
11/11/2014US8883462 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
11/06/2014US20140330010 Phenylpyrrole derivative
11/06/2014US20140330008 Process for the preparation of boronic acid intermediates
11/06/2014US20140329858 Cyclic Urea Derivatives As Androgen Receptor Antagonists
11/06/2014US20140329848 Deuterated amlexanox
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877975 Cycloalkylamines as monoamine reuptake inhibitors
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877927 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors
11/04/2014US8877796 Spiro-oxindole MDM2 antagonists
11/04/2014US8877783 Isoxazolo-pyridine derivatives
11/04/2014US8877782 Isoxazolo-pyridine derivatives
11/04/2014US8877745 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
10/2014
10/30/2014US20140323726 Methods for synthesizing molybdopterin precursor Z derivatives
10/30/2014US20140323721 Heterocyclic compounds and uses thereof
10/30/2014US20140323533 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323448 sGC STIMULATORS
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/23/2014US20140316144 Antiviral compounds
10/23/2014US20140315956 Small molecule inhibitors of il-6 and uses thereof
10/23/2014US20140315923 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
10/23/2014US20140315919 Highly selective sigma receptor ligands
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315894 Anti-cancer compounds targeting ral gtpases and methods of using the same
10/23/2014US20140315881 Compounds and methods
10/23/2014US20140315856 Aminopyrazole derivative
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865903 Continuous process for the alkylation of cyclic tertiary amines
10/21/2014US8865735 Solid forms of a pharmaceutically active substance
10/21/2014US8865716 Dihydropteridinones II
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/21/2014US8865699 Amino triazoles as PI3K inhibitors
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/16/2014US20140309432 Antiviral compounds
10/16/2014US20140309253 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde 10a)
10/16/2014US20140309248 Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
10/16/2014US20140309237 Compounds that modulate intracellular calcium
10/16/2014US20140309220 Benzoxazines as modulators of ion channels
10/16/2014US20140309216 Pharmaceutical compounds
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140308342 Reprogramming urokinase into an antibody-recruiting anticancer agent
10/14/2014US8859782 Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
10/14/2014US8859777 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
10/14/2014US8859762 Methods for ultrasonication-assisted chlorination of aromatic compounds
10/14/2014US8859584 TRPV1 antagonists
10/14/2014US8859578 Natural product derivatives with antiprotozoal activity
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859512 Anti-viral pyrimidine nucleoside derivatives
10/14/2014US8859466 Oxaspirocyclic spiro-substituted tetramic acid and tetronic acid derivatives
10/09/2014WO2014164968A1 Novel compounds for the treatment of hepatitis c
10/09/2014WO2014163162A1 Heterocyclic compound
10/09/2014US20140303373 Crystalline form of tiotropium bromide
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303152 Benzothiazinethione derivatives and preparation methods and uses thereof
10/09/2014US20140303147 Acylated derivative of homoharringtonine, preparation method therefor, and application thereof
10/09/2014US20140303143 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
10/08/2014EP2785718A1 Process for the preparation of asenapine intermediate
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853416 Chemical compounds
10/07/2014US8853403 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/07/2014US8853151 Pro-drug complexes and related methods of use
10/07/2014US8852756 Materials for organic electroluminescent devices
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014159690A1 Dna-pk inhibitors
10/02/2014WO2014159559A1 Fused furans for the treatment of hepatitis c
10/02/2014WO2014158045A1 Dimeric quaternary pyridinium salts possessing biocidal activity
10/02/2014WO2014157708A1 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device
10/02/2014WO2014157599A1 Light-emitting element, compound, organic compound, display module, lighting module, light-emitting device, display device, lighting device, and electronic device
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157009A1 Photoelectric conversion element, imaging element and optical sensor
10/02/2014WO2014156773A1 Aromatic heterocyclic compound, manufacturing method thereof, organic semiconductor material, and organic semiconductor device
10/02/2014US20140296537 Fused heterocyclic derivative and pharmaceutical use thereof
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296214 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
10/02/2014US20140296200 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
10/02/2014US20140295437 Cyanine compounds and their application as quenching compounds
10/02/2014US20140294805 Novel compounds and compositions for the inhibition of nampt
10/01/2014EP2784077A1 Norepinephrine and selective serotonin receptor blocker and use thereof
10/01/2014EP2782916A1 Carboxy x rhodamine analogs
09/2014
09/30/2014US8846951 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846926 Forms of tiotropium bromide and processes for preparation thereof
09/30/2014US8846925 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846906 5HT2C receptor modulators
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 298